# OnCo record pace-b (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/pace-b/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "pace-b", "NCT01584258" ;
  schema:name "PACE-B"@en ;
  schema:description "PACE-B showed that five stereotactic treatments control low- and intermediate-risk prostate cancer as well as four to eight weeks of conventional radiotherapy, with similar side effects at five years."@en ;
  schema:url <https://onco.cc/trials/pace-b/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01584258>, <https://doi.org/10.1056/NEJMoa2403365>, <https://doi.org/10.1056/NEJMoa2403365>, <https://doi.org/10.1016/j.eururo.2026.05.034>, <https://doi.org/10.1016/j.eururo.2025.07.007> ;
  onco:status "positive" ;
  onco:tag "radiation-wave2" ;
  onco:phase "3" ;
  schema:startDate "2012-08-07" ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-low-risk/>, <https://onco.cc/cancers/prostate-intermediate-risk/> ;
  onco:technologies <https://onco.cc/technologies/sbrt/>, <https://onco.cc/technologies/hypofractionated-radiotherapy/> ;
  onco:institutions <https://onco.cc/institutions/royal-marsden/>, <https://onco.cc/institutions/icr-london/> ;
  onco:terms <https://onco.cc/terms/prostate-radiotherapy-fractionation/>, <https://onco.cc/terms/prostate-treatment-choice-localised/> ;
  onco:trials <https://onco.cc/trials/hypo-rt-pc/>, <https://onco.cc/trials/chhip/>, <https://onco.cc/trials/partiqol/> ;
  onco:people <https://onco.cc/people/nicholas-van-as/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-van-as-n-engl-j-med/>, <https://onco.cc/key-papers/paper-pace-b-lancet-oncol-2019/>, <https://onco.cc/key-papers/paper-pace-b-lancet-oncol-2022-update/> .